A second U.S. company is poised to begin a small safety test of a vaccine against the new coronavirus.
Inovio Pharmaceuticals said Monday that it has Food and Drug
Administration permission for the study in 40 healthy volunteers in
Philadelphia and Kansas City, Mo.
The study is a first step to see if the vaccine appears safe enough
for larger tests needed to prove whether it will protect. Even if the
research goes well, it is expected to take over a year before any
vaccine could be widely available.
Last month, the first safety test in people of a different vaccine
candidate began in Seattle. It was developed by the National Institutes
of Health and Moderna Inc.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.